The response to second-line induction with bortezomib and dexamethasone is predictive of long-term outcomes prior to high-dose chemotherapy with autologous stem cell transplantation for multiple myeloma.
暂无分享,去创建一个
M. Taniwaki | H. Kaneko | S. Horiike | J. Kuroda | Y. Tsutsumi | M. Nakao | Y. Kamitsuji | N. Uoshima | T. Iwai | H. Uchiyama | C. Shimazaki | S. Murakami | D. Shimizu | Yosuke Matsumoto | A. Okano | T. Akaogi | Tsutomu Kobayashi | Yutaka Kobayashi | M. Hatsuse | R. Takahashi | S. Fuchida | Eri Kawata-Iida